Simulations Plus Inc (SLP) recently presented its vision regarding the incorporation of artificial intelligence in drug development.
The company emphasizes the transformative potential of AI technologies in enhancing efficiency and innovation within the pharmaceutical industry.
As the sector evolves, SLP's insights may provide a glimpse into the future landscape of drug development driven by AI advancements.